Investment: Rosemont Pharmaceuticals

Business: Highly specialised pharmaceutical business

Location: Leeds

Deal size: £93m

Turnover: n/d

Rosemont is a highly specialised pharmaceutical business developing and manufacturing oral liquid formulations of off-patent solid dose pharmaceutical products.

The majority of the oral liqid medicines which Rosemont produces are unique as most pharmaceutical manufacturers, including the brand originators, rarely develop liquid versions of their products. Rosemont's oral liquids are prescribed to patients who are unable (due to swallowing difficulties) or unwilling to take solid dose medications. Most of these patients are either elderley or the very young.